We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-15.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$138M
AUM Growth
-$54.6M
Cap. Flow
-$14.6M
Cap. Flow %
-10.54%
Top 10 Hldgs %
60.84%
Holding
122
New
13
Increased
15
Reduced
28
Closed
30

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.49M
2
ADTN icon
Adtran
ADTN
+$2.33M
3
VIR icon
Vir Biotechnology
VIR
+$2.27M
4
SSYS icon
Stratasys
SSYS
+$1.84M
5
PUBM icon
PubMatic
PUBM
+$1.47M

Top Sells

Rank Stock Value
1
TRIL
Trillium Therapeutics Inc.
TRIL
+$8.18M
2
AFRM icon
Affirm
AFRM
+$2.92M
3
UPST icon
Upstart Holdings
UPST
+$2.87M
4
NUAN
Nuance Communications, Inc.
NUAN
+$2.06M
5
ATRA icon
Atara Biotherapeutics
ATRA
+$1.81M

Sector Composition

Rank Sector Weight
1 Healthcare 81.55%
2 Technology 7%
3 Communication Services 4.59%
4 Consumer Discretionary 2.09%
5 Energy 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEGG
51
Sports Entertainment Gaming Global Corp
SEGG
$8.64M
$389K 0.28%
+44
New +$603K
CRIS icon
52
Curis
CRIS
$8.85M
$381K 0.28%
200
– –
DOCN icon
53
DigitalOcean
DOCN
$14.6B
$361K 0.26%
+4,500
New +$421K
ADAP
54
DELISTED
Adaptimmune Therapeutics
ADAP
$338K 0.24%
90,000
– –
MRKR icon
55
Marker Therapeutics
MRKR
$19M
$337K 0.24%
35,440
-8,500
-19% -$113K
DPRO
56
Draganfly
DPRO
$161M
$318K 0.23%
7,800
+1,800
+30% +$128K
AKRO
57
DELISTED
Akero Therapeutics
AKRO
$286K 0.21%
13,500
-9,500
-41% -$211K
RYTM icon
58
Rhythm Pharmaceuticals
RYTM
$7.59B
$274K 0.2%
27,500
-3,500
-11% -$39.3K
CCJ icon
59
Cameco
CCJ
$41.1B
$262K 0.19%
+12,000
New +$290K
AUD
60
DELISTED
Audacy, Inc.
AUD
$251K 0.18%
97,500
– –
MDNA
61
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$249K 0.18%
152,500
-197,500
-56% -$410K
OYST
62
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$247K 0.18%
13,500
-18,000
-57% -$228K
SIOX
63
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$239K 0.17%
185,000
– –
ATNM icon
64
Actinium Pharmaceuticals
ATNM
$23.5M
$225K 0.16%
37,500
– –
ABTC
65
American Bitcoin Corp
ABTC
$477M
$224K 0.16%
4
-4
-50% -$302K
ORIO
66
Orion Digital Corp
ORIO
$15.6M
$188K 0.14%
18,333
– –
HSDT icon
67
Solana Company
HSDT
$100M
$183K 0.13%
1
-1
-50% -$356K
APLT
68
DELISTED
Applied Therapeutics
APLT
$179K 0.13%
20,000
-17,500
-47% -$230K
TIL icon
69
Instil Bio
TIL
$49.2M
$171K 0.12%
500
– –
CYT
70
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$171K 0.12%
15,000
– –
AMPE
71
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$166K 0.12%
972
– –
ENLV icon
72
Enlivex Ltd
ENLV
$36.7M
$156K 0.11%
1,667
-3,833
-70% -$451K
LTRYW icon
73
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$785
$149K 0.11%
+125,000
New +$257K
CTSO icon
74
Cytosorbents Corp
CTSO
$24.2M
$147K 0.11%
35,000
– –
ATRA icon
75
Atara Biotherapeutics
ATRA
$76.9M
$145K 0.1%
368
-4,308
-92% -$1.81M
1 2
3
4 5

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, ACT Capital Management held 122 positions worth $138M, down 28% from $193M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

ACT Capital Management withdrew a net $14.6M in Q4 2021, closing 30 positions and reducing 28 holdings. Its most notable exit was Trillium Therapeutics Inc., an estimated $8.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 79% a quarter earlier, followed by Technology and Communication Services.

Against the trend, ACT Capital Management opened a new position in Meta Platforms (Facebook) worth $2.52M.

  • ACT Capital Management's largest Q4 2021 buy was Meta Platforms (Facebook): 7,500 shares worth $2.52M.
  • ACT Capital Management added most to Stratasys in Q4 2021, an estimated $1.84M increase.
  • ACT Capital Management's biggest Q4 2021 reduction was Upstart Holdings, cutting an estimated $2.87M.
  • ACT Capital Management fully exited Trillium Therapeutics Inc. in Q4 2021, selling an estimated $8.18M.
  • ACT Capital Management's ten largest holdings make up 61% of its $138M portfolio in Q4 2021.
  • ACT Capital Management opened 13 new positions and closed 30 in Q4 2021.
  • ACT Capital Management's portfolio value fell 28% quarter-over-quarter to $138M.

Based on ACT Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.